Article
Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.
Pharmacogenetics - 1 Dec 1999
McLeod H L, Pritchard S C, Githang'a J, Indalo A, Ameyaw M M, Powrie R H, Booth L, Collie-Duguid E S
Abstract excerpt
Thiopurine methyltransferase (TPMT) degrades 6-mercaptopurine, azathioprine and 6-thioguanine which are commonly used in the treatment of autoimmune diseases, leukaemia and organ transplantation. TPMT activity is polymorphic as a result of gene mutations. Heterozygous individuals have an increased risk of haematological toxicity after thiopurine medication, while homozygous mutant individuals suffer life...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
